denkapparat Operations’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$667K Buy
2,702
+108
+4% +$27.5K 0.18% 225
2026
Q2
$781K Buy
2,594
+1,562
+151% +$471K 0.26% 151
2026
Q1
$341K Buy
1,032
+120
+13% +$40.8K 0.14% 255
2025
Q4
$363K Buy
+912
New +$404K 0.2% 208

Other funds holding ALNY

denkapparat Operations's ALNY Position: Q3 2026 in Review

denkapparat Operations increased its Alnylam Pharmaceuticals (ALNY) stake by 4.2% in Q3 2026, buying an estimated $27.5K and bringing the position to 2,702 shares worth $667K. The position accounts for 0.18% of the portfolio, ranked #225.

denkapparat Operations first reported a position in ALNY in Q4 2025 and has held it in 4 quarters since. The position peaked at $781K in Q2 2026. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • denkapparat Operations held 2,702 shares of Alnylam Pharmaceuticals worth $667K as of Q3 2026.
  • denkapparat Operations bought 108 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $27.5K.
  • Alnylam Pharmaceuticals made up 0.18% of denkapparat Operations's portfolio in Q3 2026, its #225 holding.
  • denkapparat Operations first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • denkapparat Operations's Alnylam Pharmaceuticals position peaked at $781K in Q2 2026.
  • 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on denkapparat Operations's 13F filing for Q3 2026, filed 9 Nov 2026.